Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$14.85 n/a | n/a%
12/24/14 - 01:00 PM ET
Company Profile
Price and Volume
Recent Price 14.85
52 Week High 16.25
52 Week Low 12.27
Avg. Daily Vol. (Mil) 0.28
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 493.88
Shares Out (Mil) 33.26
Float (Mil) 17.59
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.10
Current Ratio 2.50
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 179.53
Price/Book 0.00
Price/Cash Flow -9.30
Per Share Data
Earnings -2.80
Sales 0.08
Book Value 0.00
Cash Flow -1.60
Business Summary
Coherus BioSciences Inc is a late-stage clinical biologics platform company. The Company is engaged in developing biosimilar therapeutics.
General Information
201 Redwood Shores Parkway
Suite 200
Redwood City, CA 94065
www.coherus.com
Industry : Drugs
Sector: Health Care
Employees: 57
CEO: Dennis M. Lanfear
Short Interest
Current Month (Mil) 0.07
Previous Month (Mil) 0.06
Short Interest Ratio (Days) 0.50
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter